GSK Cancer R&D Chief Sees Three Key Approvals In Q2

Says “Will Help Anchor” Oncology Pipeline.

 
• By Sten Stovall
  
Cancer_Research
Axel Hoos says GSK is successfully re-entering oncology’s commercial space • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip